dr. mittendorf highlights fda approval of atezolizumab/nab-paclitaxel in pd-l1 tnbc
Published 5 years ago • 686 plays • Length 2:38Download video MP4
Download video MP3
Similar videos
-
1:17
dr. hamilton on fda approval of atezolizumab/nab-paclitaxel in tnbc
-
1:16
dr. lynce on fda approval of atezolizumab/nab-paclitaxel in tnbc
-
0:13
copy of dr. hamilton on fda approval of atezolizumab/nab-paclitaxel in tnbc
-
7:05
the fda approval of atezolizumab in bladder cancer
-
7:08
impassion130: results of atezolizumab plus nab-paclitaxel for frontline tnbc
-
1:08
dr. horn on the fda approval of atezolizumab plus bevacizumab and chemotherapy in nsclc
-
3:12
atezolizumab with nab-paclitaxel improves survival in breast cancer patients
-
1:48
dr. saeed rafii on atezolizumab/ nab-paclitaxel in tnbc
-
5:59
impassion130: atezolizumab and nab-paclitaxel in triple-negative breast cancer
-
1:03
dr. kalinsky on clinical impact of atezolizumab combo in tnbc
-
4:15
impassion130: atezolizumab (atezo) nab-paclitaxel (nab-p) vs placebo nab-p in treatment-naiv...
-
4:45
atezolizumab plus nab-paclitaxel for advanced triple negative breast cancer
-
8:42
chemoimmunotherapy in tnbc: the impassion130 trial
-
1:12
dr. mittendorf discusses immunotherapy efforts in breast cancer
-
5:45
case 3: atezolizumab/nab-paclitaxel for triple negative breast cancer
-
8:25
study of nab-paclitaxel with pembrolizumab for patients with hr /her2- breast cancer
-
0:54
dr. o’donnell on challenges with pd-l1 testing in bladder cancer
-
3:16
survival with atezolizumab and nab-paclitaxel versus nab-paclitaxel alone among patients with advanc
-
3:02
dr. ou on the fda approval of pembrolizumab in sclc